Related Experiment Video
Updated: Jun 6, 2026

07:01
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
Published on: April 17, 2013
A solid thyroid benign nodule that showed a significant decrease in size and ultrasonographic findings mimicking
Yasuhiro Ito1, Nobuyuki Amino, Mitsuyoshi Hirokawa
1Department of Surgery, Kuma Hospital, 8-2-35 Shimoyamate-dori, Chuo-ku, Kobe, Japan. ito01@kuma-h.or.jp
Endocrine Journal
|November 25, 2010
Summary
Ultrasonography can suggest malignancy in thyroid nodules, but fine needle aspiration biopsy (FNAB) may diagnose them as benign. This case highlights that benign nodules can change over time, presenting diagnostic challenges.
Area of Science:
- Endocrinology
- Oncology
- Radiology
Background:
- Accurate diagnosis of thyroid nodules is crucial for treatment.
- Ultrasonography and fine needle aspiration biopsy (FNAB) are key diagnostic tools.
- Discordance between ultrasonography and FNAB findings presents treatment challenges.
Observation:
- A 28-year-old female presented with a large, benign-diagnosed thyroid nodule.
- Over time, the nodule decreased in size but developed ultrasonographic features suggestive of malignancy.
- Repeated FNAB confirmed the nodule as benign despite suspicious imaging.
Findings:
- The case illustrates a benign thyroid nodule evolving with malignant-appearing ultrasonographic characteristics.
- Spontaneous regression and changing imaging features in benign nodules can mimic malignancy.
- Persistent benign FNAB results despite suspicious imaging warrant careful consideration.
Implications:
- Clinicians should consider the possibility of benign nodule degeneration when imaging suggests malignancy but cytology is negative.
- This phenomenon challenges current diagnostic paradigms for thyroid nodules.
- Further research is needed to understand the mechanisms and clinical significance of such evolving benign nodules.
Related Concept Videos
Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
